A preliminary diagnosis of lysozyme amyloidosis was formulated after a clinical analysis of the manifestations: hemorrhagic syndrome as a dominant clinical sign, an autosomal dominant inheritance of the disease, and the absence of the necessary prerequisites for the development of other more frequent forms of systemic amyloidosis. The gene discussed is LYZ; the disease is primary systemic amyloidosis.